What Adults Need to Know About the New RSV Vaccines
### New RSV Vaccines: What Adults Need to Know
What is RSV?
Respiratory syncytial virus (RSV) is a common respiratory virus that can cause mild, cold-like symptoms or severe respiratory problems, especially in infants and older adults. Most people are infected with RSV at least once by the age of 2. RSV is the most common cause of bronchiolitis and pneumonia in children under the age of 1, and it can also cause serious illness in older adults, especially those with weakened immune systems.
What are the symptoms of RSV?
The symptoms of RSV are similar to those of other respiratory viruses, including:
- Runny nose
- Sore throat
- Cough
- Difficulty breathing
- Wheezing
- Fever
- Loss of appetite
- Vomiting
- Diarrhea
Who is at risk of severe RSV infection?
Infants, young children, and older adults are at highest risk of severe RSV infection. People with certain underlying medical conditions, such as heart disease, lung disease, or a weakened immune system, are also at increased risk.
What are the treatments for RSV?
There is no specific treatment for RSV, and treatment is focused on relieving symptoms. Treatment may include:
- Over-the-counter pain relievers and fever reducers
- Rest
- Fluids
- Humidified air
- Oxygen therapy (for severe cases)
How can RSV be prevented?
There are no vaccines currently available to prevent RSV infection. However, several new RSV vaccines are in development and may be available in the coming years. These vaccines will likely be recommended for infants, young children, and older adults.
What should adults do to protect themselves from RSV?
Adults can help protect themselves from RSV by taking the following precautions:
- Washing hands frequently with soap and water
- Avoiding contact with people who are sick
- Covering their mouths and noses when coughing or sneezing
- Staying home from work or school if sick
- Getting vaccinated against influenza (the flu)
When will the new RSV vaccines be available?
Several new RSV vaccines are currently in development and may be available in the coming years. The exact timeline for the availability of these vaccines is not yet known.
What are the potential risks and benefits of the new RSV vaccines?
The potential risks and benefits of the new RSV vaccines are not yet fully known. However, based on the results of clinical trials, the vaccines appear to be safe and effective in preventing RSV infection. The vaccines may cause some mild side effects, such as injection site pain, fever, and headache. These side effects are typically mild and go away within a few days.
Will the new RSV vaccines be recommended for everyone?
The exact recommendations for the use of the new RSV vaccines are not yet known. However, it is likely that the vaccines will be recommended for infants, young children, and older adults.